US Stock MarketDetailed Quotes

Atara Biotherapeutics (ATRA)

Watchlist
  • 5.150
  • +0.260+5.32%
Close Apr 14 16:00 ET
  • 5.150
  • 0.0000.00%
Post 16:10 ET
42.12MMarket Cap2.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atara Biotherapeutics (ATRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-6.33%120.77M
-95.13%1.6M
-91.41%3.45M
-38.63%17.58M
258.77%98.15M
1,404.02%128.94M
670.30%32.75M
1,779.79%40.19M
2,892.69%28.64M
2,131.40%27.36M
Operating revenue
-6.33%120.77M
-95.13%1.6M
-91.41%3.45M
-38.63%17.58M
258.77%98.15M
1,404.02%128.94M
670.30%32.75M
1,779.79%40.19M
2,892.69%28.64M
2,131.40%27.36M
Cost of revenue
0.97%21.21M
-98.47%104K
-98.49%115K
-88.03%554K
929.67%20.44M
136.43%21.01M
115.03%6.8M
190.71%7.6M
59.83%4.63M
818.98%1.99M
Gross profit
-7.76%99.56M
-94.26%1.49M
-89.76%3.34M
-29.12%17.02M
206.28%77.71M
34,582.75%107.93M
2,277.11%25.96M
6,931.87%32.59M
1,339.06%24.01M
2,412.08%25.37M
Operating expense
-66.71%63.7M
-89.38%4.05M
-87.28%6.91M
-68.65%13.25M
-31.28%38.91M
-30.59%191.37M
-37.50%38.16M
-21.39%54.35M
-39.20%42.24M
-25.53%56.62M
Selling and administrative expenses
-34.18%26.25M
-54.69%4.28M
-61.74%3.99M
-33.40%5.94M
3.26%11.48M
-21.65%39.89M
-17.58%9.44M
-14.91%10.42M
-33.17%8.91M
-19.89%11.11M
-General and administrative expense
-34.18%26.25M
-54.69%4.28M
-61.74%3.99M
-33.40%5.94M
3.26%11.48M
-21.65%39.89M
-17.58%9.44M
-14.91%10.42M
-33.17%8.91M
-19.89%11.11M
Research and development costs
-75.28%37.45M
-100.78%-223K
-93.34%2.93M
-78.07%7.31M
-39.72%27.43M
-32.61%151.48M
-42.09%28.72M
-22.79%43.92M
-40.63%33.33M
-26.79%45.51M
Operating profit
142.98%35.86M
79.00%-2.56M
83.57%-3.57M
120.71%3.78M
224.18%38.8M
69.77%-83.44M
79.65%-12.2M
68.75%-21.76M
74.47%-18.23M
58.35%-31.25M
Net non-operating interest income expense
-24.11%-3.11M
-89.05%-794K
2.62%-705K
-2.09%-829K
-42.26%-781K
-1,876.60%-2.51M
9.68%-420K
-309.04%-724K
-356.15%-812K
-217.81%-549K
Non-operating interest income
-67.63%683K
-83.25%100K
-55.56%204K
-68.22%143K
-60.93%236K
-61.11%2.11M
-16.03%597K
-62.32%459K
-73.45%450K
-66.48%604K
Non-operating interest expense
-17.83%3.79M
-12.09%894K
-23.16%909K
-22.98%972K
-11.80%1.02M
-12.68%4.62M
-13.52%1.02M
-15.20%1.18M
-8.42%1.26M
-13.70%1.15M
Other net income (expense)
-106.44%-34K
44.94%-49K
-99.28%4K
-9,183.33%-557K
-116.18%-11K
314.63%528K
-641.67%-89K
2,155.56%555K
40.00%-6K
134.52%68K
Special income (charges)
----
----
----
---579K
----
----
----
----
--0
----
-Less：Restructuring and merger&acquisition
----
----
----
--579K
----
----
----
----
--0
----
Other non- operating income (expenses)
-106.44%-34K
44.94%-49K
-99.28%4K
466.67%22K
-116.18%-11K
314.63%528K
-641.67%-89K
2,155.56%555K
40.00%-6K
134.52%68K
Income before tax
138.31%32.72M
73.21%-3.41M
80.50%-4.28M
112.55%2.39M
219.80%38.01M
69.06%-85.42M
78.97%-12.71M
68.59%-21.93M
73.21%-19.05M
57.55%-31.73M
Income tax
358.33%31K
0
264.71%28K
3K
0
-180.00%-12K
-272.73%-19K
10.53%-17K
0
9.09%24K
Net income
138.28%32.69M
73.17%-3.41M
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
Net income continuous Operations
138.28%32.69M
73.17%-3.41M
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
Minority interest income
Net income attributable to the parent company
138.28%32.69M
73.17%-3.41M
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
138.28%32.69M
73.17%-3.41M
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
Basic earnings per share
122.87%2.61
70.59%-0.35
89.08%-0.32
106.45%0.2
162.48%3.53
82.50%-11.41
91.45%-1.19
82.13%-2.93
81.67%-3.1
68.61%-5.65
Diluted earnings per share
122.52%2.57
69.75%-0.36
89.08%-0.32
106.13%0.19
161.95%3.5
82.50%-11.41
91.45%-1.19
82.13%-2.93
81.67%-3.1
68.61%-5.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -6.33%120.77M-95.13%1.6M-91.41%3.45M-38.63%17.58M258.77%98.15M1,404.02%128.94M670.30%32.75M1,779.79%40.19M2,892.69%28.64M2,131.40%27.36M
Operating revenue -6.33%120.77M-95.13%1.6M-91.41%3.45M-38.63%17.58M258.77%98.15M1,404.02%128.94M670.30%32.75M1,779.79%40.19M2,892.69%28.64M2,131.40%27.36M
Cost of revenue 0.97%21.21M-98.47%104K-98.49%115K-88.03%554K929.67%20.44M136.43%21.01M115.03%6.8M190.71%7.6M59.83%4.63M818.98%1.99M
Gross profit -7.76%99.56M-94.26%1.49M-89.76%3.34M-29.12%17.02M206.28%77.71M34,582.75%107.93M2,277.11%25.96M6,931.87%32.59M1,339.06%24.01M2,412.08%25.37M
Operating expense -66.71%63.7M-89.38%4.05M-87.28%6.91M-68.65%13.25M-31.28%38.91M-30.59%191.37M-37.50%38.16M-21.39%54.35M-39.20%42.24M-25.53%56.62M
Selling and administrative expenses -34.18%26.25M-54.69%4.28M-61.74%3.99M-33.40%5.94M3.26%11.48M-21.65%39.89M-17.58%9.44M-14.91%10.42M-33.17%8.91M-19.89%11.11M
-General and administrative expense -34.18%26.25M-54.69%4.28M-61.74%3.99M-33.40%5.94M3.26%11.48M-21.65%39.89M-17.58%9.44M-14.91%10.42M-33.17%8.91M-19.89%11.11M
Research and development costs -75.28%37.45M-100.78%-223K-93.34%2.93M-78.07%7.31M-39.72%27.43M-32.61%151.48M-42.09%28.72M-22.79%43.92M-40.63%33.33M-26.79%45.51M
Operating profit 142.98%35.86M79.00%-2.56M83.57%-3.57M120.71%3.78M224.18%38.8M69.77%-83.44M79.65%-12.2M68.75%-21.76M74.47%-18.23M58.35%-31.25M
Net non-operating interest income expense -24.11%-3.11M-89.05%-794K2.62%-705K-2.09%-829K-42.26%-781K-1,876.60%-2.51M9.68%-420K-309.04%-724K-356.15%-812K-217.81%-549K
Non-operating interest income -67.63%683K-83.25%100K-55.56%204K-68.22%143K-60.93%236K-61.11%2.11M-16.03%597K-62.32%459K-73.45%450K-66.48%604K
Non-operating interest expense -17.83%3.79M-12.09%894K-23.16%909K-22.98%972K-11.80%1.02M-12.68%4.62M-13.52%1.02M-15.20%1.18M-8.42%1.26M-13.70%1.15M
Other net income (expense) -106.44%-34K44.94%-49K-99.28%4K-9,183.33%-557K-116.18%-11K314.63%528K-641.67%-89K2,155.56%555K40.00%-6K134.52%68K
Special income (charges) ---------------579K------------------0----
-Less：Restructuring and merger&acquisition --------------579K------------------0----
Other non- operating income (expenses) -106.44%-34K44.94%-49K-99.28%4K466.67%22K-116.18%-11K314.63%528K-641.67%-89K2,155.56%555K40.00%-6K134.52%68K
Income before tax 138.31%32.72M73.21%-3.41M80.50%-4.28M112.55%2.39M219.80%38.01M69.06%-85.42M78.97%-12.71M68.59%-21.93M73.21%-19.05M57.55%-31.73M
Income tax 358.33%31K0264.71%28K3K0-180.00%-12K-272.73%-19K10.53%-17K09.09%24K
Net income 138.28%32.69M73.17%-3.41M80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M
Net income continuous Operations 138.28%32.69M73.17%-3.41M80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M
Minority interest income
Net income attributable to the parent company 138.28%32.69M73.17%-3.41M80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 138.28%32.69M73.17%-3.41M80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M
Basic earnings per share 122.87%2.6170.59%-0.3589.08%-0.32106.45%0.2162.48%3.5382.50%-11.4191.45%-1.1982.13%-2.9381.67%-3.168.61%-5.65
Diluted earnings per share 122.52%2.5769.75%-0.3689.08%-0.32106.13%0.19161.95%3.582.50%-11.4191.45%-1.1982.13%-2.9381.67%-3.168.61%-5.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -